BioRem Inc. (TSXV:BRM)

BioRem Statistics

Total Valuation

BioRem has a market cap or net worth of CAD 51.15 million. The enterprise value is 43.81 million.

Market Cap	51.15M
Enterprise Value	43.81M

Important Dates

The next estimated earnings date is Friday, May 22, 2026.

Earnings Date	May 22, 2026
Ex-Dividend Date	n/a

Share Statistics

BioRem has 16.13 million shares outstanding. The number of shares has decreased by -1.39% in one year.

Current Share Class	16.13M
Shares Outstanding	16.13M
Shares Change (YoY)	-1.39%
Shares Change (QoQ)	+9.40%
Owned by Insiders (%)	2.00%
Owned by Institutions (%)	n/a
Float	15.81M

Valuation Ratios

The trailing PE ratio is 11.75.

PE Ratio	11.75
Forward PE	n/a
PS Ratio	1.15
PB Ratio	3.34
P/TBV Ratio	3.34
P/FCF Ratio	40.40
P/OCF Ratio	28.19
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.07, with an EV/FCF ratio of 34.61.

EV / Earnings	8.80
EV / Sales	0.99
EV / EBITDA	6.07
EV / EBIT	6.45
EV / FCF	34.61

Financial Position

The company has a current ratio of 2.02, with a Debt / Equity ratio of 0.17.

Current Ratio	2.02
Quick Ratio	1.55
Debt / Equity	0.17
Debt / EBITDA	0.37
Debt / FCF	2.09
Interest Coverage	44.10

Financial Efficiency

Return on equity (ROE) is 38.33% and return on invested capital (ROIC) is 72.65%.

Return on Equity (ROE)	38.33%
Return on Assets (ROA)	14.21%
Return on Invested Capital (ROIC)	72.65%
Return on Capital Employed (ROCE)	39.34%
Weighted Average Cost of Capital (WACC)	8.52%
Revenue Per Employee	1.31M
Profits Per Employee	146,493
Employee Count	34
Asset Turnover	1.49
Inventory Turnover	11.14

Taxes

In the past 12 months, BioRem has paid 1.57 million in taxes.

Income Tax	1.57M
Effective Tax Rate	23.96%

Stock Price Statistics

The stock price has increased by +66.19% in the last 52 weeks. The beta is 0.81, so BioRem's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	+66.19%
50-Day Moving Average	2.85
200-Day Moving Average	2.44
Relative Strength Index (RSI)	63.46
Average Volume (20 Days)	57,777

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioRem had revenue of CAD 44.44 million and earned 4.98 million in profits. Earnings per share was 0.27.

Revenue	44.44M
Gross Profit	13.05M
Operating Income	6.79M
Pretax Income	6.55M
Net Income	4.98M
EBITDA	7.08M
EBIT	6.79M
Earnings Per Share (EPS)	0.27

Balance Sheet

The company has 9.99 million in cash and 2.65 million in debt, with a net cash position of 7.34 million or 0.45 per share.

Cash & Cash Equivalents	9.99M
Total Debt	2.65M
Net Cash	7.34M
Net Cash Per Share	0.45
Equity (Book Value)	15.30M
Book Value Per Share	0.91
Working Capital	14.51M

Cash Flow

In the last 12 months, operating cash flow was 1.81 million and capital expenditures -548,337, giving a free cash flow of 1.27 million.

Operating Cash Flow	1.81M
Capital Expenditures	-548,337
Depreciation & Amortization	291,191
Net Borrowing	-661,802
Free Cash Flow	1.27M
FCF Per Share	0.08

Margins

Gross margin is 29.36%, with operating and profit margins of 15.27% and 11.21%.

Gross Margin	29.36%
Operating Margin	15.27%
Pretax Margin	14.74%
Profit Margin	11.21%
EBITDA Margin	15.93%
EBIT Margin	15.27%
FCF Margin	2.85%

Dividends & Yields

BioRem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.39%
Shareholder Yield	1.39%
Earnings Yield	9.74%
FCF Yield	2.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7